SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-008122
Filing Date
2022-05-06
Accepted
2022-05-06 16:01:11
Documents
14
Period of Report
2022-05-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20220506.htm   iXBRL 8-K 62341
2 EX-99.1 allk-ex99_1.htm EX-99.1 178258
3 GRAPHIC img113759291_0.jpg GRAPHIC 16758
  Complete submission text file 0000950170-22-008122.txt   389252

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT allk-20220506_lab.xml EX-101.LAB 12890
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT allk-20220506_pre.xml EX-101.PRE 10599
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT allk-20220506.xsd EX-101.SCH 2497
8 EXTRACTED XBRL INSTANCE DOCUMENT allk-20220506_htm.xml XML 4515
Mailing Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065
Business Address 975 ISLAND DRIVE SUITE 201 REDWOOD CITY CA 94065 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 22900931
SIC: 2834 Pharmaceutical Preparations